Prothioconazole has been shown to be an inhibitor of expression of the AHR target Cyp1a1 in a mouse hepatoma cell line [25], while thiabendazole actived a mouse PXR-dependent reporter system in vitro [79]. The gene discussed is AHR; the disease is hepatocellular carcinoma.